Trial Profile
Nateglinide: a double blind add-on study with pioglitazone for type 2 diabetic patients
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 14 Dec 2006
Price :
$35
*
At a glance
- Drugs Nateglinide (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 14 Dec 2006 Status change
- 11 Dec 2005 New trial record.